Web Notifications

SaltWire.com would like to send you notifications for breaking news alerts.

Activate notifications?

German regulators approve trial of French group Abivax's coronavirus product

STORY CONTINUES BELOW THESE SALTWIRE VIDEOS

Sustainable Wines for Earth Day | SaltWire #reels #EarthDay #shorts

Watch on YouTube: "Sustainable Wines for Earth Day | SaltWire #reels #EarthDay #shorts"

PARIS (Reuters) - French biotech group Abivax said on Monday German regulators had approved a trial to test its 'ABX464' product to help COVID-19 patients, following earlier French regulatory approval.

Abivax said it received funding of 36 million euros ($39.20 million) from French state bank BPIfrance for the product, and added it hoped to win regulatory approval in other countries such as Belgium, Britain, Italy and Spain.

(Reporting by Sudip Kar-Gupta; Editing by Clarence Fernandez)

Share story:
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT